Skip to main content
IQV
NYSE Industrial Applications And Services

IQVIA Q2 Revenue and EPS Top High End of Guidance; Backlog Reaches $34.2B

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$242.94
Mkt Cap
$40.547B
52W Low
$154.5
52W High
$247.718
52W Position info
57% above low
Off High info
1.9% below high
Rel. Volume info
3.0× avg
Market data snapshot near publication time

IQV sits 57% above its 52-week low of $154.5 on elevated volume (3.0× avg).

Summary

IQVIA's Q2 2026 results exceeded the high end of its own guidance, with revenue of $4.37 billion and adjusted EPS of $3.15. The backlog grew to $34.2 billion, and the company repurchased $950 million in shares during the first half.


Key Events · Earnings and Guidance · IQV

  • Q2 Revenue and EPS Beat Guidance

    Revenue of $4.37 billion and adjusted diluted EPS of $3.15 both exceeded the high end of the company's prior guidance, driven by 8.6% growth in Commercial Solutions and 8.8% growth in Research & Development Solutions.

  • Record Backlog of $34.2 Billion

    Research & Development Solutions' contracted backlog reached $34.2 billion as of June 30, 2026, up from $34.0 billion at year-end 2025, with approximately $9.2 billion expected to convert to revenue in the next twelve months.

  • Aggressive Share Repurchases Continue

    IQVIA repurchased 5.5 million shares for $950 million in the first half of 2026, with $2.819 billion remaining under its repurchase authorization following a $2 billion increase approved in May 2026.

  • Restructuring Costs Elevated

    Restructuring costs were $63 million in Q2 and $114 million in H1 2026, as the company continues to streamline operations and reduce overcapacity; actions are expected to continue into 2027.


Analysis · IQV · Industrial Applications And Services

IQVIA delivered Q2 revenue of $4.37 billion and adjusted EPS of $3.15, both above the high end of its prior guidance. Broad-based growth across both segments fueled the beat, with Commercial Solutions up 8.6% and Research & Development Solutions up 8.8%. A record contracted backlog of $34.2 billion signals strong future revenue visibility. Against this backdrop, the company continued its aggressive capital return, repurchasing $950 million in shares during the first half, with $2.8 billion remaining under its authorization. While restructuring costs remain elevated as operations are streamlined, the underlying business momentum is clear.

How filings like this one have moved

In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IQV was trading at $242.94 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $40.5B. The 52-week trading range was $154.50 to $247.72. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IQV - Latest Insights

IQV
Sep 09, 2026, 8:15 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $265.26
Real-time Price: $261.77 info
Change: -$3.49 (-1%) info
Market Cap: $43.087B info
IQV
Jul 31, 2026, 5:02 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $235.02
Real-time Price: $261.77 info
Change: +$26.75 (+11%) info
Market Cap: $43.087B info
IQV
Jul 28, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $234.00
Real-time Price: $261.77 info
Change: +$27.77 (+12%) info
Market Cap: $43.087B info
IQV
Jul 28, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $234.00
Real-time Price: $261.77 info
Change: +$27.77 (+12%) info
Market Cap: $43.087B info
IQV
Jun 11, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $181.06
Real-time Price: $261.77 info
Change: +$80.71 (+45%) info
Market Cap: $43.087B info